Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nordentoft

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Social Psychiatry and Psychiatric Epidemiology|January 10, 1998
Copenhagen Community Psychiatric Project (CCPP): characteristics and treatment of homeless patients in the psychiatric services after introduction of community mental health centresM Nordentoft, H C Knudsen, B Jessen-Petersen, et al.
Psychological Medicine|April 7, 2017
Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-upD R Gotfredsen, R S Wils, C Hjorthøj, et al.
Schizophrenia Research|June 13, 2018
Impact of severe mental illness on cancer stage at diagnosis and subsequent mortality: A population-based register studyA Toender, T Munk-Olsen, M Vestergaard, et al.
Acta Psychiatrica Scandinavica|September 16, 2009
An intron 1 polymorphism in the cholecystokinin-A receptor gene associated with schizophrenia in malesP Koefoed, T V O Hansen, D P D Woldbye, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 17, 2021
EPA guidance on treatment of negative symptoms in schizophreniaS Galderisi, S Kaiser, I Bitter, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2021
EPA guidance on assessment of negative symptoms in schizophreniaS Galderisi, A Mucci, S Dollfus, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 9, 2020
Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 monthsC Wenneberg, B Y Glenthøj, L B Glenthøj, et al.
Scandinavian Journal of Haematology|July 1, 1980
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRAN I Nissen, A M Nordentoft, H Brincker, et al.
Psychological Medicine|September 23, 2016
Psychosocial therapy and causes of death after deliberate self-harm: a register-based, nationwide multicentre study using propensity score matchingJ Birkbak, E A Stuart, B D Lind, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 10, 2015
EPA guidance on the early intervention in clinical high risk states of psychosesS J Schmidt, F Schultze-Lutter, B G Schimmelmann, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Social Psychiatry and Psychiatric Epidemiology|January 10, 1998
Copenhagen Community Psychiatric Project (CCPP): characteristics and treatment of homeless patients in the psychiatric services after introduction of community mental health centresM Nordentoft, H C Knudsen, B Jessen-Petersen, et al.
Psychological Medicine|April 7, 2017
Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-upD R Gotfredsen, R S Wils, C Hjorthøj, et al.
Schizophrenia Research|June 13, 2018
Impact of severe mental illness on cancer stage at diagnosis and subsequent mortality: A population-based register studyA Toender, T Munk-Olsen, M Vestergaard, et al.
Acta Psychiatrica Scandinavica|September 16, 2009
An intron 1 polymorphism in the cholecystokinin-A receptor gene associated with schizophrenia in malesP Koefoed, T V O Hansen, D P D Woldbye, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 17, 2021
EPA guidance on treatment of negative symptoms in schizophreniaS Galderisi, S Kaiser, I Bitter, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2021
EPA guidance on assessment of negative symptoms in schizophreniaS Galderisi, A Mucci, S Dollfus, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 9, 2020
Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 monthsC Wenneberg, B Y Glenthøj, L B Glenthøj, et al.
Scandinavian Journal of Haematology|July 1, 1980
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRAN I Nissen, A M Nordentoft, H Brincker, et al.
Psychological Medicine|September 23, 2016
Psychosocial therapy and causes of death after deliberate self-harm: a register-based, nationwide multicentre study using propensity score matchingJ Birkbak, E A Stuart, B D Lind, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 10, 2015
EPA guidance on the early intervention in clinical high risk states of psychosesS J Schmidt, F Schultze-Lutter, B G Schimmelmann, et al.
Pageof 10